BG107604A - Тартаратна сол на тиазолидиндионово производно - Google Patents

Тартаратна сол на тиазолидиндионово производно Download PDF

Info

Publication number
BG107604A
BG107604A BG107604A BG10760403A BG107604A BG 107604 A BG107604 A BG 107604A BG 107604 A BG107604 A BG 107604A BG 10760403 A BG10760403 A BG 10760403A BG 107604 A BG107604 A BG 107604A
Authority
BG
Bulgaria
Prior art keywords
tartrate
solvate
accordance
compound according
pyridyl
Prior art date
Application number
BG107604A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Craig
Tim HO
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG107604A publication Critical patent/BG107604A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Cosmetics (AREA)
BG107604A 2000-08-04 2003-02-28 Тартаратна сол на тиазолидиндионово производно BG107604A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019224.5A GB0019224D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003511 WO2002012232A1 (en) 2000-08-04 2001-08-03 Tartrate salt of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
BG107604A true BG107604A (bg) 2003-09-30

Family

ID=9897026

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107604A BG107604A (bg) 2000-08-04 2003-02-28 Тартаратна сол на тиазолидиндионово производно

Country Status (37)

Country Link
US (1) US20040014790A1 (de)
EP (1) EP1305311B1 (de)
JP (1) JP2004505970A (de)
KR (1) KR100755174B1 (de)
CN (1) CN1455778A (de)
AP (1) AP1785A (de)
AT (1) ATE384059T1 (de)
AU (1) AU2001276506A1 (de)
BG (1) BG107604A (de)
BR (1) BR0112982A (de)
CA (1) CA2417827A1 (de)
CY (1) CY1107252T1 (de)
CZ (1) CZ2003313A3 (de)
DE (1) DE60132461T2 (de)
DK (1) DK1305311T3 (de)
DZ (1) DZ3418A1 (de)
EA (1) EA005408B1 (de)
EC (1) ECSP034467A (de)
ES (1) ES2296772T3 (de)
GB (1) GB0019224D0 (de)
HK (1) HK1057358A1 (de)
HR (1) HRP20030068B1 (de)
HU (1) HUP0300778A3 (de)
IL (2) IL154275A0 (de)
MA (1) MA25832A1 (de)
MX (1) MXPA03001085A (de)
NO (1) NO324596B1 (de)
NZ (1) NZ524030A (de)
OA (1) OA12354A (de)
PL (1) PL360662A1 (de)
PT (1) PT1305311E (de)
SI (1) SI1305311T1 (de)
SK (1) SK1462003A3 (de)
UA (1) UA76720C2 (de)
WO (1) WO2002012232A1 (de)
YU (1) YU14603A (de)
ZA (1) ZA200300961B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
WO2017072770A1 (en) 2015-10-27 2017-05-04 Nanopass Technologies Ltd. Microneedle device with mechanical guide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
AP1785A (en) 2007-10-04
NO20030530L (no) 2003-02-03
CY1107252T1 (el) 2012-11-21
GB0019224D0 (en) 2000-09-27
AP2003002736A0 (en) 2003-03-31
WO2002012232A1 (en) 2002-02-14
MA25832A1 (fr) 2003-07-01
CZ2003313A3 (cs) 2004-02-18
KR100755174B1 (ko) 2007-09-03
ZA200300961B (en) 2004-04-01
ECSP034467A (es) 2003-03-31
NO20030530D0 (no) 2003-02-03
PT1305311E (pt) 2008-04-07
SI1305311T1 (sl) 2008-04-30
EP1305311B1 (de) 2008-01-16
HUP0300778A2 (hu) 2003-11-28
HRP20030068A2 (en) 2005-02-28
EA005408B1 (ru) 2005-02-24
PL360662A1 (en) 2004-09-20
US20040014790A1 (en) 2004-01-22
OA12354A (en) 2004-03-19
CA2417827A1 (en) 2002-02-14
BR0112982A (pt) 2003-08-26
DE60132461T2 (de) 2008-12-24
SK1462003A3 (en) 2004-06-08
AU2001276506A1 (en) 2002-02-18
DK1305311T3 (da) 2008-05-19
NZ524030A (en) 2004-07-30
DZ3418A1 (fr) 2002-02-14
ATE384059T1 (de) 2008-02-15
IL154275A (en) 2009-02-11
ES2296772T3 (es) 2008-05-01
YU14603A (sh) 2006-05-25
MXPA03001085A (es) 2003-05-27
HUP0300778A3 (en) 2005-04-28
CN1455778A (zh) 2003-11-12
IL154275A0 (en) 2003-09-17
NO324596B1 (no) 2007-11-26
UA76720C2 (uk) 2006-09-15
HRP20030068B1 (en) 2008-07-31
JP2004505970A (ja) 2004-02-26
EA200300230A1 (ru) 2003-06-26
DE60132461D1 (de) 2008-03-06
EP1305311A1 (de) 2003-05-02
KR20030022355A (ko) 2003-03-15
HK1057358A1 (en) 2004-04-02

Similar Documents

Publication Publication Date Title
BG107606A (bg) Тартаратни соли на тиазолидиндионово производно
BG107607A (bg) Хидрохлоридна сол на 5-[4-[2-(n-метил-n-(2-пиридил)амино)етокси]бензил]тиазолидин-2,4-дион
BG107604A (bg) Тартаратна сол на тиазолидиндионово производно
BG107605A (bg) Тартаратни соли на тиазолидиндионово производно
KR20030007918A (ko) 당뇨병 치료용 티아졸리딘디온 염
KR100917953B1 (ko) 5-[4-[2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시]벤질]티아졸리딘-2,4-디온의 나트륨염
BG107603A (bg) Тартаратни соли на тиазолидиндионово производно
EA004298B1 (ru) Гидроиодид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона в качестве фармацевтического препарата
US20040102485A1 (en) Tartrate salt of thiazolidinedione derivative
PT1325000E (pt) Derivado de tiazolidinodiona e sua utilização como antidiabético
KR20040062963A (ko) 5-(4-(2-(ｎ-메틸-ｎ-(2-피리딜)아미노)에톡시)벤질)티아졸리딘-2,4-디온 벤젠술포네이트, 그의 제조 방법, 그의다형체 ⅰ, ⅱ 및 ⅲ, 및 제약상 활성 성분으로서의 그의용도